RhumbLine Advisers’s Agilon Health AGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.07M | Buy |
463,331
+23,550
| +5% | +$54.2K | ﹤0.01% | 2210 |
|
|
2025
Q1 | $1.9M | Buy |
439,781
+20,194
| +5% | +$87.4K | ﹤0.01% | 1828 |
|
|
2024
Q4 | $797K | Buy |
419,587
+24,420
| +6% | +$46.4K | ﹤0.01% | 2367 |
|
|
2024
Q3 | $1.55M | Sell |
395,167
-37,852
| -9% | -$149K | ﹤0.01% | 2037 |
|
|
2024
Q2 | $2.83M | Buy |
433,019
+84,573
| +24% | +$553K | ﹤0.01% | 1703 |
|
|
2024
Q1 | $2.13M | Sell |
348,446
-33,094
| -9% | -$202K | ﹤0.01% | 1882 |
|
|
2023
Q4 | $4.79M | Buy |
381,540
+4,988
| +1% | +$62.6K | 0.01% | 1443 |
|
|
2023
Q3 | $6.69M | Buy |
376,552
+23,552
| +7% | +$418K | 0.01% | 1192 |
|
|
2023
Q2 | $6.12M | Buy |
353,000
+120,945
| +52% | +$2.1M | 0.01% | 1259 |
|
|
2023
Q1 | $5.51M | Buy |
232,055
+13,056
| +6% | +$310K | 0.01% | 1256 |
|
|
2022
Q4 | $3.54M | Buy |
218,999
+20,389
| +10% | +$329K | ﹤0.01% | 1488 |
|
|
2022
Q3 | $4.65M | Buy |
198,610
+14,431
| +8% | +$338K | 0.01% | 1278 |
|
|
2022
Q2 | $4.02M | Buy |
184,179
+37,279
| +25% | +$814K | 0.01% | 1360 |
|
|
2022
Q1 | $3.72M | Sell |
146,900
-7,004
| -5% | -$178K | ﹤0.01% | 1492 |
|
|
2021
Q4 | $4.16M | Buy |
153,904
+97,407
| +172% | +$2.63M | 0.01% | 1464 |
|
|
2021
Q3 | $1.48M | Buy |
56,497
+11,585
| +26% | +$304K | ﹤0.01% | 2051 |
|
|
2021
Q2 | $1.82M | Buy |
+44,912
| New | +$1.82M | ﹤0.01% | 1998 |
|